These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
81 related articles for article (PubMed ID: 27143351)
21. A retrospective database analysis of neuropathic pain and oral antidiabetic medication use and adherence among Texas adults with type 2 diabetes enrolled in Medicaid. Oladapo AO; Barner JC; Rascati KL; Strassels SA Clin Ther; 2012 Mar; 34(3):605-13. PubMed ID: 22386828 [TBL] [Abstract][Full Text] [Related]
22. Survey nonresponders incurred higher medical utilization and lower medication adherence. Rinne ST; Wong ES; Lemon JM; Perkins M; Bryson CL; Liu CF Am J Manag Care; 2015 Jan; 21(1):e1-8. PubMed ID: 25880264 [TBL] [Abstract][Full Text] [Related]
23. Establishing an on-site pharmacy in a community health center to help indigent patients access medications and to improve care. Dent LA; Stratton TP; Cochran GA J Am Pharm Assoc (Wash); 2002; 42(3):497-507. PubMed ID: 12030637 [TBL] [Abstract][Full Text] [Related]
24. Safe and effective use of medicines for patients with type 2 diabetes - A randomized controlled trial of two interventions delivered by local pharmacies. Kjeldsen LJ; Bjerrum L; Dam P; Larsen BO; Rossing C; Søndergaard B; Herborg H Res Social Adm Pharm; 2015; 11(1):47-62. PubMed ID: 24798710 [TBL] [Abstract][Full Text] [Related]
25. Comparisons of rosiglitazone versus pioglitazone monotherapy introduction and associated health care utilization in Medicaid-enrolled patients with type 2 diabetes mellitus. Balkrishnan R; Arondekar BV; Camacho FT; Shenolikar RA; Horblyuk R; Anderson RT Clin Ther; 2007 Jun; 29(6 Pt 1):1306-15. PubMed ID: 18036392 [TBL] [Abstract][Full Text] [Related]
26. Medical utilization and costs associated with statin adherence in Medicaid enrollees with type 2 diabetes. Wu J; Seiber E; Lacombe VA; Nahata MC; Balkrishnan R Ann Pharmacother; 2011 Mar; 45(3):342-9. PubMed ID: 21325098 [TBL] [Abstract][Full Text] [Related]
27. The effects of health plan copayments on adherence to oral diabetes medication and health resource utilization. Colombi AM; Yu-Isenberg K; Priest J J Occup Environ Med; 2008 May; 50(5):535-41. PubMed ID: 18469622 [TBL] [Abstract][Full Text] [Related]
28. Economic impact of compliance to treatment with antidiabetes medication in type 2 diabetes mellitus: a review paper. Breitscheidel L; Stamenitis S; Dippel FW; Schöffski O J Med Econ; 2010 Mar; 13(1):8-15. PubMed ID: 19947905 [TBL] [Abstract][Full Text] [Related]
29. The Utah Remote Monitoring Project: improving health care one patient at a time. Shane-McWhorter L; Lenert L; Petersen M; Woolsey S; McAdam-Marx C; Coursey JM; Whittaker TC; Hyer C; LaMarche D; Carroll P; Chuy L Diabetes Technol Ther; 2014 Oct; 16(10):653-60. PubMed ID: 24991923 [TBL] [Abstract][Full Text] [Related]
30. Impact of a physician-led point of care medication delivery system on medication adherence. Palacio A; Chen J; Tamariz L; Garay SD; Li H; Carrasquillo O Am J Manag Care; 2016 Jul; 22(7):e264-9. PubMed ID: 27442310 [TBL] [Abstract][Full Text] [Related]
31. [Clinical and economic benefits of the new antidiabetic drugs in the Czech Republic]. Doležal T; Kruntorádová K Vnitr Lek; 2015 Nov; 61(11 Suppl 3):3S50-3. PubMed ID: 26652966 [TBL] [Abstract][Full Text] [Related]
32. Clinical pharmacy specialists' impact in patient aligned care teams for type 2 diabetes management. Bloom CI; Ku M; Williams M J Am Pharm Assoc (2003); 2019; 59(5):717-721. PubMed ID: 31204200 [TBL] [Abstract][Full Text] [Related]
33. Utilizing clinical video telehealth to improve access and optimize pharmacists' role in diabetes management. Baker JW; Forkum W; McNeal J J Am Pharm Assoc (2003); 2019; 59(2S):S63-S66. PubMed ID: 30738723 [TBL] [Abstract][Full Text] [Related]
34. Determinants of diabetes-attributable non-blood glucose-lowering medication costs in type 2 diabetes: the Fremantle Diabetes Study. Davis WA; Knuiman MW; Hendrie D; Davis TM Diabetes Care; 2005 Feb; 28(2):329-36. PubMed ID: 15677788 [TBL] [Abstract][Full Text] [Related]
35. Diabetes care improvement in pharmacist- versus nurse-supported patient-centered medical homes. Min L; Cigolle CT; Bernstein SJ; Ward K; Moore TL; Ha J; Blaum CS Am J Manag Care; 2017 Nov; 23(11):e374-e381. PubMed ID: 29182358 [TBL] [Abstract][Full Text] [Related]
36. Effect of increased cost-sharing on oral hypoglycemic use in five managed care organizations: how much is too much? Roblin DW; Platt R; Goodman MJ; Hsu J; Nelson WW; Smith DH; Andrade SE; Soumerai SB Med Care; 2005 Oct; 43(10):951-9. PubMed ID: 16166864 [TBL] [Abstract][Full Text] [Related]
37. Impact of the clinical pharmacy specialist in telehealth primary care. Litke J; Spoutz L; Ahlstrom D; Perdew C; Llamas W; Erickson K Am J Health Syst Pharm; 2018 Jul; 75(13):982-986. PubMed ID: 29941537 [TBL] [Abstract][Full Text] [Related]
38. Impact of a Bilingual Pharmacy Diabetes Service in a Federally Qualified Health Center. Chavez B; Kosirog E; Brunner JM Ann Pharmacother; 2018 Dec; 52(12):1218-1223. PubMed ID: 29871511 [TBL] [Abstract][Full Text] [Related]
39. Outcomes of Project Dulce: a culturally specific diabetes management program. Gilmer TP; Philis-Tsimikas A; Walker C Ann Pharmacother; 2005 May; 39(5):817-22. PubMed ID: 15769828 [TBL] [Abstract][Full Text] [Related]
40. Using pharmacy technicians and electronic health record capabilities to improve outcomes for patients with cardiovascular disease. Olson KL; Stine JM; Stadler SL; Angleson J; Campbell SM; Friesleben C; Schimmer JJ J Am Pharm Assoc (2003); 2022; 62(2):604-611. PubMed ID: 34753672 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]